Have a personal or library account? Click to login
Various clinical presentations of uveitis associated with durvalumab treatment Cover

Various clinical presentations of uveitis associated with durvalumab treatment

Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
By: Nika Vrabic,  Ana Fakin,  Polona Jaki Mekjavic,  Urska Janzic,  Martina Vrankar and  Natasa Vidovic Valentincic  
Open Access
|Apr 2022

Authors

Nika Vrabic

vrabicnika@gmail.com

University Eye Clinic, University Clinical Centre Ljubljana, Ljubljana, Slovenia

Ana Fakin

University Eye Clinic, University Clinical Centre Ljubljana, Ljubljana, Slovenia

Polona Jaki Mekjavic

University Eye Clinic, University Clinical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Jožef Stefan Institute, Ljubljana, Slovenia

Urska Janzic

University Clinic of Pulmonary and Allergic Diseases Golnik, Ljubljana, Slovenia

Martina Vrankar

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Natasa Vidovic Valentincic

University Eye Clinic, University Clinical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2022-0007 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 129 - 137
Submitted on: Nov 24, 2021
Accepted on: Jan 10, 2022
Published on: Apr 12, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
durvalumab,
uveitis,
optic disc oedema,
immune checkpoint inhibitor,
adverse effects
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Nika Vrabic, Ana Fakin, Polona Jaki Mekjavic, Urska Janzic, Martina Vrankar, Natasa Vidovic Valentincic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 56 (2022): Issue 2 (June 2022)Next article